Literature DB >> 8612516

Up-regulation of cyclooxygenase-2 gene expression by chorionic gonadotropin during the differentiation of human endometrial stromal cells into decidua.

S W Han1, Z M Lei, C V Rao.   

Abstract

Human endometrial stromal cells contain human CG (hCG)/LH receptors and in vitro, hCG/LH can promote stromal cells differentiation into decidua. In the present study, we tested the hypothesis that the treatment of stromal cells with exogenous hCG/LH to promote in up-regulation of cyclooxygenase-2 (COX-2) gene expression. The stromal cells from proliferative phase endometria were cultured for 10 days with 10 ng/ml estradiol and 100 ng/ml progesterone in the presence or absence of increasing concentrations of highly purified hCG. Northern blotting demonstrated that the cells contained a 4.4-kb COX-2 messenger RNA transcript whose levels significantly increased after treatment with hCG. Western blotting showed that the cells contained a 72-kDa COX-2 protein which also significantly increased after treatment with hCG. The effect of hCG on COX-2 messenger RNA and protein was seen at 10 ng/ml and higher concentrations sustained the increased levels. Although human LH mimicked hCG, human FSH, TSH, and isolated alpha- and beta-subunits of hCG had no effect on COX-2 protein levels suggesting that the hCG effect is hormone specific and requires the conformation of native hormone. The effect of hCG on COX-2 protein paralleled the increase in media prostaglandin E2 levels indicating that the increased COX-2 gene and half-life of its transcripts to determine the molecular mechanism of hCG action. The results showed that hCG treatment had no significant effect on transcription rate of the COX-2 gene. On the other hand, treatment with hCG significantly increased the half-life of the COX-2 transcripts from 2.6 h in the control to 6.7 h after treatment. In summary, we conclude that treatment of human endometrial stromal cells with exogenous hCG to promote their differentiation into decidua results in an up-regulation of COX-2 gene expression by increasing the stability of the transcripts.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8612516     DOI: 10.1210/endo.137.5.8612516

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  11 in total

Review 1.  The role of chorionic gonadotropin and Notch1 in implantation.

Authors:  Yalda Afshar; Adina Stanculescu; Lucio Miele; Asgerally T Fazleabas
Journal:  J Assist Reprod Genet       Date:  2007-07       Impact factor: 3.412

2.  Heightened expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-delta in human endometrial adenocarcinoma.

Authors:  B J Tong; J Tan; L Tajeda; S K Das; J A Chapman; R N DuBois; S K Dey
Journal:  Neoplasia       Date:  2000 Nov-Dec       Impact factor: 5.715

3.  Modulation of the baboon (Papio anubis) uterine endometrium by chorionic gonadotrophin during the period of uterine receptivity.

Authors:  A T Fazleabas; K M Donnelly; S Srinivasan; J D Fortman; J B Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

4.  Evidence for expression and functionality of FSH and LH/hCG receptors in human endometrium.

Authors:  Sandro Sacchi; Paola Sena; Chiara Degli Esposti; Jessica Lui; Antonio La Marca
Journal:  J Assist Reprod Genet       Date:  2018-07-04       Impact factor: 3.412

5.  KN-93, a specific inhibitor of CaMKII inhibits human hepatic stellate cell proliferation in vitro.

Authors:  Ping An; Jun-Yong Zhu; Yan Yang; Peng Lv; Yi-Hao Tian; Ming-Kai Chen; He-Sheng Luo
Journal:  World J Gastroenterol       Date:  2007-03-07       Impact factor: 5.742

6.  Rosiglitazone inhibits alpha4 nicotinic acetylcholine receptor expression in human lung carcinoma cells through peroxisome proliferator-activated receptor gamma-independent signals.

Authors:  Xiaojuan Sun; Jeffrey D Ritzenthaler; Ying Zheng; Jesse Roman; ShouWei Han
Journal:  Mol Cancer Ther       Date:  2009-01       Impact factor: 6.261

7.  Nicotine stimulates PPARbeta/delta expression in human lung carcinoma cells through activation of PI3K/mTOR and suppression of AP-2alpha.

Authors:  XiaoJuan Sun; Jeffrey D Ritzenthaler; XiaoRong Zhong; Ying Zheng; Jesse Roman; ShouWei Han
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

8.  Activation of peroxisome proliferator-activated receptor beta/delta induces lung cancer growth via peroxisome proliferator-activated receptor coactivator gamma-1alpha.

Authors:  Shouwei Han; Jeffrey D Ritzenthaler; Xiaojuan Sun; Ying Zheng; Jesse Roman
Journal:  Am J Respir Cell Mol Biol       Date:  2008-09-05       Impact factor: 6.914

9.  Caveolin-1 Regulation and Function in Mouse Uterus during Early Pregnancy and under Human In Vitro Decidualization.

Authors:  Zhuo Song; Bo Li; Mengyuan Li; Jiamei Luo; Yuqi Hong; Yuying He; Siting Chen; Zhenshan Yang; Chen Liang; Zengming Yang
Journal:  Int J Mol Sci       Date:  2022-03-28       Impact factor: 5.923

10.  Rosiglitazone, an Agonist of PPARgamma, Inhibits Non-Small Cell Carcinoma Cell Proliferation In Part through Activation of Tumor Sclerosis Complex-2.

Authors:  Shouwei Han; Ying Zheng; Jesse Roman
Journal:  PPAR Res       Date:  2007       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.